Zobrazeno 1 - 10
of 21
pro vyhledávání: '"N. I. Geyvandova"'
Autor:
M. V. Maevskaya, M. Yu. Nadinskaia, E. N. Bessonova, N. I. Geyvandova, M. S. Zharkova, E. A. Kitsenko, N. V. Korochanskaya, I. A. Kurkina, A. L. Melikyan, V. G. Morozov, Yu. V. Khoronko, T. A. Deeva, K. A. Gulyaeva, V. T. Ivashkin
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 34, Iss 3, Pp 115-134 (2024)
Introduction. As a result of portal hypertension (sequestration of platelets in an enlarged spleen) and liver failure (decreased production of thrombopoietin in the liver) in liver cirrhosis, thrombocytopenia develops, which is associated with the ri
Externí odkaz:
https://doaj.org/article/b386bf93f6834d9dbfe6e6aca09034ee
Autor:
M. V. Maevskaya, V. D. Lunkov, N. I. Geyvandova, L. K. Palgova, I. Yu. Pirogova, M. K. Prashnova, N. V. Marchenko, E. N. Zinovieva, T. A. Ilchishina, V. T. Ivashkin, P. V. Koroy
Publikováno v:
Медицинский совет, Vol 0, Iss 15, Pp 78-89 (2020)
Introduction. The increase in serum transaminases (ALT and AST) and the persistence of their high values is associated with morbidity and mortality from liver diseases. Bicyclol has anti-inflammatory and antioxidant effects, which formed the basis fo
Externí odkaz:
https://doaj.org/article/b81f10d8b7224f1fa30bd7ebc33da855
Autor:
M. V. Maevskaya, E. N. Bessonova, N. I. Geyvandova, E. A. Kitsenko, N. V. Korochanskaia, V. G. Morozov, Y. V. Khoronko
Publikováno v:
Meditsinskiy sovet = Medical Council. :142-147
Seven of the country’s leading experts in the field of therapeutic and surgical hepatology answer questions on this issue: how relevant is thrombocytopenia in patients with CLD for clinical practice, what is the average proportion of patients who n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14cceabf5e8414771e145ffca182df04
https://doi.org/10.21518/2079-701x-2022-16-23-2
https://doi.org/10.21518/2079-701x-2022-16-23-2
Autor:
I. G. Bakulin, N. A. Bokhan, P. O. Bogomolov, N. I. Geyvandova, M. V. Matsiyevich, M. A. Vinnikova, V. G. Morozov, O. M. Khromtsova, G. S. Soldatova, O. Yu. Shiryayev, R. D. Ilyuk, K. V. Rybakova, A. G. Katkovskaya, S. V. Teplykh, A. A. Bagretsova, M. V. Krasnova, Ye. V. Alekseyeva, A. V. Anipchenko, Ye. V. Baskakov
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 27, Iss 3, Pp 57-68 (2018)
Material and methods. The original study included overall 120 patients with ALD, who were randomized in two identical groups. The patients of the main group (group A) received 2 courses of therapy: the first - Phosphogliv 5 mg/day as intravenous bolu
Externí odkaz:
https://doaj.org/article/4f495eb6776240bda9501c18da8c6da0
Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial)
Autor:
Marina V. Mayevskaya, Ye. N. Bessonova, P. O. Bogomolov, N. I. Geyvandova, K. V. Zhdanov, V. G. Morozov, V. D. Pasechnikov, I. Yu. Khomenko, A. V. Yagoda, V. T. Ivashkin
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 26, Iss 6, Pp 69-83 (2018)
Aim of investigation. Nowadays the question, whether pegylated interferon should be completely abandoned in the treatment of chronic hepatitis C (CHC) is still open. Beneficial interferon properties include: absence of mutagenic capacity for hepatiti
Externí odkaz:
https://doaj.org/article/14e4f35f52b640b1807d773161107b05
Autor:
V. T. Ivashkin, I. G. Bakulin, P. O. Bogomolov, M. V. Matsiyevich, N. I. Geyvandova, P. V. Koroy, S. V. Nedogoda, O. A. Sablin, L. G. Lenskaya, Ye. V. Beloborodova, A. A. Bagretsova, R. A. Abdulkhakov, M. F. Osipenko, I. V. Osipova, D. A. Pocheptsov, Ye. V. Chumachek, O. M. Khromtsova, Ye. V. Kuzmicheva
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 27, Iss 2, Pp 34-43 (2018)
Aim of investigation. To estimate efficacy and safety of two pharmacological forms of «Phosphogliv» (lyophilizate for intravenous administration and capsules) for the treatment of fatty liver degeneration of non-alcoholic etiology. Material and met
Externí odkaz:
https://doaj.org/article/4131ff0071c74aa1ac7482e20794c338
Autor:
V. T. Ivashkin, M. V. Mayevskaya, D. T. Abdurakhmanov, I. G. Bakulin, N. I. Geyvandova, M. L. Zubkin, S. N. Kizhlo, A. V. Kuznetsova, I. B. Latysheva, N. A. Mamonova, V. G. Morozov, O. I. Sagalova, Ye. V. Esaulenko, Ye. O. Lyusina
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 27, Iss 6, Pp 52-62 (2018)
Introduction. The options of antiviral therapy (AVT) in the stages of severe liver fibrosis and cirrhosis (LC) as well as in the patients with comorbidities for the long time were limited to the standard therapy by pegilated interferon (peg-IFN) in c
Externí odkaz:
https://doaj.org/article/648fb9a0265848459515bd7b7ee40f58
Autor:
M. V. Mayevskaya, V. T. Ivashkin, O. O. Znoyko, Ye. A. Klimova, D. T. Abdurakhmanov, I. G. Bakulin, P. O. Bogomolov, E. Z. Burnevich, M. Yu. Galushko, N. I. Geyvandova, K. V. Zhdanov, Ye. V. Esaulenko, S. N. Kizhlo, D. Yu. Konstantinov, N. I. Mironova, V. G. Morozov, Ye. A. Strebkova, I. G. Nikitin, M. F. Osipenko, V. D. Pasechnikov, O. I. Sagalova, I. M. Khayertynova, V. P. Chulanov, A. A. Yakovlev, I. A. Vasyutin, Ye. P. Tarkhova, E. N. Krasavina, M. Yu. Samsonov
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 27, Iss 6, Pp 41-51 (2018)
Aim of investigation. To estimate efficacy and safety of narlaprevir (NVR) with ritonavir (RTV), pegilated interferon (peg-IFN) and ribavirin (RBV) at treatmentnaïve and earlier treated noncirrhotic patients with chronic hepatitis C caused by the 1s
Externí odkaz:
https://doaj.org/article/0686acb179664d0d893a6a2414c4957c
Autor:
M. V. Maevskaya, M. S. Zharkova, V. T. Ivashkin, E. N. Bessonova, N. I. Geyvandova, E. A. Kitsenko, N. V. Korochanskaya, I. A. Kurkina, A. L. Melikyan, V. G. Morozov, Yu. V. Khoronko
Publikováno v:
Meditsinskiy sovet = Medical Council. :70-82
Hemostasis disorders in cirrhosis / severe liver disease are complex, as they affect both pro- and anticoagulant factors, as well as pro- and antifibrinolytic components. Most of the tests that are used in clinical practice to assess coagulation do n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b27b67fe99d68ec752bfcd8fe94289a
https://doi.org/10.21518/2079-701x-2022-16-15-70-82
https://doi.org/10.21518/2079-701x-2022-16-15-70-82
Publikováno v:
Медицинский совет, Vol 0, Iss 14, Pp 68-74 (2016)
Introduction in practice of therapeutic establishments in the RF of antiviral therapy of chronic viral hepatitis in the form of interferon-free schemes led to considerable increase of the frequency of the stable virologic response. Study objective: d
Externí odkaz:
https://doaj.org/article/5e835d095ebf4632b748aa9cc38f8b9d